Richard Pazdur Appointed Director of the FDA’s Drug Center: A New Chapter for Cancer Regulation / OncoDaily

oncodaily - Dr. Richard Pazdur, one of the most influential figures in oncology drug regulation, has been appointed Director of the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and […]

#healthcare #pharmaceuticals #publichealth #governmentpolicy #drugdevelopment #fda

FDA announces new regulatory pathway for personalized rare disease therapies

4 months / endpoints / Jared Whitlock

Pazdur vs. Prasad: Can the CDER-CBER dynamic change under new leadership?

4 months / endpoints / Zachary Brennan

Patrick Soon-Shiong: Expanded Access is Not Enough… Withholding FDA Approval Impacts Quality Care

4 months / oncodaily

Richard Pazdur, longtime FDA oncology leader, to head agency’s main drug office

4 months / healthcaredive / Kristin Jensen

FDA taps longtime oncology lead as drug center chief

4 months / beckershospitalreview / Ella Jeffries

Richard Pazdur Appointed Director of the FDA’s Drug Center: A New Chapter for Cancer Regulation

4 months / oncodaily

F.D.A. Names Agency Veteran to Run Drug Division

4 months / nytimes / Christina Jewett and Rebecca Robbins

FDA taps Richard Pazdur as new CDER director after Tidmarsh's resignation

4 months / endpoints / Alexis Kramer

Wednesday, November 12, 2025, 6:22 am / permalink 15886 / 8 stories in 4 months

Related Stories

FDA Abortion Pill Decisions Rooted in Science / 1 month
FDA loosens data restrictions to accelerate drug reviews / 2 months
FDA approves leucovorin for rare folate disorder despite autism hype / 34 hrs
FDA launches individualized therapy framework for ultra-rare diseases / 20 days
FDA makes one pivotal trial the default for drug approvals / 25 days
FDA refuses to review Moderna mRNA flu vaccine application / 4 wks
FDA rejects Atara cell therapy for Epstein–Barr virus complications / 2 months

Related Tags

Healthcare

EPA proposes rollback on ethylene oxide sterilizer emissions (20 min)

Two deaths prompt probe of paid plasma donation clinics in Winnipeg (1 hr)

HIMSS 2026 pushes real‑time data, cloud and interoperability playbook (18 hrs)

more #healthcare

Pharmaceuticals

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma (19 hrs)

Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival (22 hrs)

FDA approves leucovorin for rare folate disorder despite autism hype (34 hrs)

more #pharmaceuticals

Public Health

EPA proposes rollback on ethylene oxide sterilizer emissions (20 min)

Two deaths prompt probe of paid plasma donation clinics in Winnipeg (1 hr)

Vitamin D trial shows reduced long‑COVID risk but no severity benefit (21 hrs)

more #publichealth

StackHealth Time Machine

NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.